DKTK Publikationen
Dose Escalation with Intensity-Modulated Proton Therapy for Patients with High-Risk Meningiomas - Results from a Phase I Trial.
Clinical cancer research 32(16), 3552 - 3560 (2026) [10.1158/1078-0432.CCR-25-3856]
BibTeX |
EndNote:
XML,
Text |
RIS
The challenge of patient recruitment into early phase clinical trials: Is time-effective academic translational research feasible? Lessons from a phase I/II trial in patients with B-cell deficiencies.
Frontiers in medicine 13, 1844041 (2026) [10.3389/fmed.2026.1844041]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
CXCR4-Targeted Molecular Imaging in Hematology and Oncology.
Journal of nuclear medicine nn, nn (2026) [10.2967/jnumed.126.272587]
BibTeX |
EndNote:
XML,
Text |
RIS
Coping strategies of neurosurgeons in response to major surgical complications: A nationwide questionnaire assessment in Germany
Brain and spine 6, 106258 (2026) [10.1016/j.bas.2026.106258]
BibTeX |
EndNote:
XML,
Text |
RIS
[177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2–3, gastroenteropancreatic neuroendocrine tumours: preplanned and post-hoc efficacy analyses from the randomised, phase 3 NETTER-2 trial
EClinicalMedicine 98, 104109 (2026) [10.1016/j.eclinm.2026.104109]
BibTeX |
EndNote:
XML,
Text |
RIS
Prognostic Factors and Outcomes for Post-Radiation Sarcoma-A Systematic Review and Meta-Analysis.
Cancers 18(15), 2414 (2026) [10.3390/cancers18152414]
BibTeX |
EndNote:
XML,
Text |
RIS
Mechanistic insights into phage dynamics to overcome intracellular bacterial reservoirs in urinary tract infections.
npj viruses 4(1), 38 (2026) [10.1038/s44298-026-00222-4]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
A single model for glioblastoma segmentation with and without T2-FLAIR: independent validation of a targeted dropout strategy.
Frontiers in neurology 17, 1889198 (2026) [10.3389/fneur.2026.1889198]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.
Journal of clinical oncology nn, nn (2026) [10.1200/JCO-26-00528]
BibTeX |
EndNote:
XML,
Text |
RIS
Machine learning for population-level risk prediction of future cholangiocarcinoma.
EBioMedicine 131, 106433 (2026) [10.1016/j.ebiom.2026.106433]
BibTeX |
EndNote:
XML,
Text |
RIS
A single-cell multi-omic atlas of the human pancreas reveals potential for cellular plasticity across development, health, and disease.
Cell metabolism nn, nn (2026) [10.1016/j.cmet.2026.07.023]
BibTeX |
EndNote:
XML,
Text |
RIS
Preparative leukapheresis impairs autologous donor hemostasis and platelet function
Research and practice in thrombosis and haemostasis 10(5), 106819 (2026) [10.1016/j.rpth.2026.106819]
BibTeX |
EndNote:
XML,
Text |
RIS
MOSAIC: Maximizing out-of-distribution sensitivity via aligned image classification
Computer vision and image understanding 271, 104885 (2026) [10.1016/j.cviu.2026.104885]
BibTeX |
EndNote:
XML,
Text |
RIS
Using Gene Expression Changes for Monitoring Glioblastoma WHO CNS Grade 4 Recurrence: Validation of NGS Candidate Genes via qRT-PCR
Radiation research 206(2), 197 - 206 (2026) [10.1667/RADE-25-00226.1]
BibTeX |
EndNote:
XML,
Text |
RIS
Bacterial Colonization in Resected Lymph Nodes during Pancreatic Surgery: A Pilot Study
Digestive surgery nn, nn (2026) [10.1159/000552484]
BibTeX |
EndNote:
XML,
Text |
RIS
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.
Journal of clinical oncology nn, nn (2026) [10.1200/JCO-26-00852]
BibTeX |
EndNote:
XML,
Text |
RIS
Step-brothers in arms, SAGA and ATAC co-activator complexes, use different strategies.
The EMBO journal nn, nn (2026) [10.1038/s44318-026-00892-z]
BibTeX |
EndNote:
XML,
Text |
RIS
Utilization of Functional Degradation Pathways for the Characterization of Ubiquitin-Proteasome System Tool Compounds.
Methods in molecular biology 3069, 33-51 (2026) [doi:10.1007/978-1-0716-5508-5_3]
BibTeX |
EndNote:
XML,
Text |
RIS
Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.
Cancer cell nn, nn (2026) [10.1016/j.ccell.2026.07.011]
BibTeX |
EndNote:
XML,
Text |
RIS
Robustness of radiomics-based machine learning to real-world MRI distribution shifts: a phantom study.
Physics in medicine and biology nn, nn (2026) [10.1088/1361-6560/ae97ad]
BibTeX |
EndNote:
XML,
Text |
RIS
Response to neoadjuvant chemotherapy as a potential indicator of internal mammary node involvement in early breast cancer.
International journal of radiation oncology, biology, physics nn, nn (2026) [10.1016/j.ijrobp.2026.07.050]
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: The evolving role of cytokines for CAR-T cell manufacturing and beyond.
Nature biomedical engineering nn, nn (2026) [10.1038/s41551-026-01783-8]
BibTeX |
EndNote:
XML,
Text |
RIS
Relevance of light conditions for clinical in situ Raman spectroscopy.
Frontiers in oncology 16, 1850523 (2026) [10.3389/fonc.2026.1850523]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Diffuse Skin Sclerosis in a Patient With Lung Cancer
JEADV clinical practice nn, nn (2026) [10.1002/jvc2.70415]
BibTeX |
EndNote:
XML,
Text |
RIS
Baseline dual-energy CT iodine uptake predicts systemic but not lesion-level progression in immunotherapy-treated metastatic melanoma.
European journal of radiology 204, 113137 (2026) [10.1016/j.ejrad.2026.113137]
BibTeX |
EndNote:
XML,
Text |
RIS
Durable clinical and immunologic response to an off-the-shelf EWSR1-FLI1 peptide vaccine in metastatic Ewing sarcoma.
npj precision oncology 10(1), 305 (2026) [10.1038/s41698-026-01642-4]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Five-fraction stereotactic magnetic resonance-guided adaptive radiotherapy targeting the primary tumor in metastatic pancreatic cancer
World journal of gastroenterology nn, nn (2026) [10.3748/wjg.117832]
BibTeX |
EndNote:
XML,
Text |
RIS
External validation of a top-ranked model from the RSNA pulmonary embolism detection challenge: assessment of generalizability.
Scientific reports 16(1), 24545 (2026) [10.1038/s41598-026-65551-z]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Mental health and suicidality in glioblastoma patients in germany - a multicenter cross-sectional observational study protocol (SHINE-GLIO Study).
Neurological research and practice 8(1), 61 (2026) [10.1186/s42466-026-00520-5]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Impact of apertures on the out-of-field secondary neutron dose in collimated proton pencil-beam scanning.
Physics in medicine and biology 71(15), 155022 (2026) [10.1088/1361-6560/ae873a]
BibTeX |
EndNote:
XML,
Text |
RIS
Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance.
Journal of experimental & clinical cancer research 45(1), 170 (2026) [10.1186/s13046-026-03803-6]
BibTeX |
EndNote:
XML,
Text |
RIS
Unified definition of integrated diagnostics: a position statement of the EFLM.
Clinical chemistry and laboratory medicine nn, nn (2026) [10.1515/cclm-2026-0949]
BibTeX |
EndNote:
XML,
Text |
RIS
Analysing open-source protein folding models for nanobody binding prediction.
Frontiers in bioinformatics 6, 1858891 (2026) [10.3389/fbinf.2026.1858891]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience.
Theranostics 16(14), 7926 - 7936 (2026) [10.7150/thno.129889]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Vertebral body segmentation in CT: An open dataset, deep-learning models and comparison to existing models.
European journal of radiology 204, 113118 (2026) [10.1016/j.ejrad.2026.113118]
BibTeX |
EndNote:
XML,
Text |
RIS
Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.
Gut nn, nn (2026) [10.1136/gutjnl-2025-337617]
BibTeX |
EndNote:
XML,
Text |
RIS
Structure-based scaffold hopping reveals strategies to overcome oncogenic KIT and PDGFRA mutation-driven drug-resistance in GIST.
Nature Communications 17(1), 7932 (2026) [10.1038/s41467-026-76340-7]
BibTeX |
EndNote:
XML,
Text |
RIS
CLOCK/BMAL1 interactome uncovers homeodomain factors as tissue regulators.
Nature cell biology nn, nn (2026) [10.1038/s41556-026-02041-4]
BibTeX |
EndNote:
XML,
Text |
RIS
Pegtarazimod limits acute graft-versus-host disease mortality and severity in mice and is tolerated in patients.
The journal of clinical investigation nn, nn (2026) [10.1172/JCI205864]
BibTeX |
EndNote:
XML,
Text |
RIS
Proteolysis Targeting Chimeric-Based Technology in Myeloma and Lymphoma.
Molecular cancer therapeutics 25(8), 1264 - 1280 (2026) [10.1158/1535-7163.MCT-25-1148]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.
Nature cancer nn, nn (2026) [10.1038/s43018-026-01227-x]
BibTeX |
EndNote:
XML,
Text |
RIS
Development of an artificial intelligence driven dose prediction pipeline for online adaptive magnetic resonance-guided radiotherapy
Physics & Imaging in Radiation Oncology 40, 101048 (2026) [10.1016/j.phro.2026.101048]
BibTeX |
EndNote:
XML,
Text |
RIS
SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities.
Cancer discovery 16(8), 1666 - 1690 (2026) [10.1158/2159-8290.CD-25-1458]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.
Leukemia and lymphoma nn, nn (2026) [10.1080/10428194.2026.2707442]
BibTeX |
EndNote:
XML,
Text |
RIS
Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.
Human gene therapy 37(15-16), 691-701 (2026) [10.1177/10430342261468974]
BibTeX |
EndNote:
XML,
Text |
RIS
Correction for Fassl et al., Regulation of the immune CD155–CD226–TIGIT axis by cyclin D-CDK4/6
Proceedings of the National Academy of Sciences of the United States of America 123(30), e2623204123 (2026) [10.1073/pnas.2623204123]
BibTeX |
EndNote:
XML,
Text |
RIS
Perturb-seq reveals TCF7 as a transcriptional link between MAPK- and Wnt-driven gene expression.
Nucleic acids research 54(14), gkag718 (2026) [10.1093/nar/gkag718]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [177Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA).
Journal of nuclear medicine nn, nn (2026) [10.2967/jnumed.126.272714]
BibTeX |
EndNote:
XML,
Text |
RIS
Cancer neuroscience: Mechanisms to medicine.
Science translational medicine 18(860), eaeh1718 (2026) [10.1126/scitranslmed.aeh1718]
BibTeX |
EndNote:
XML,
Text |
RIS
Tumor and Organ Dose Estimates from 177Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial.
Journal of nuclear medicine nn, nn (2026) [10.2967/jnumed.126.272574]
BibTeX |
EndNote:
XML,
Text |
RIS